Sie befinden sich hier

Inhalt

Publications with MCTN Affiliation 2024

  1. Atrial Fibrillation in Patients with Very High Risk for Stroke and Adverse Events-Insights from the Observational ARENA Study.
    Alonso A, Akin I, Hochadel M, Borggrefe M, Lesch H, Grau A, Zahn R, Lugenbiel P, Schwarzbach CJ, Sueselbeck T, Senges J, and Fastner C. J Clin Med. 2024. 13(22).
    DOI: 10.3390/jcm13226645.
  2. Understanding e-Cigarette Addictiveness: Triangulation of Focus Group and Netnographic Data.
    Andreas M, Grundinger N, Wolber N, Szafran D, Gorig T, Mons U, Lohner V, Vollstadt-Klein S, and Schneider S. J Med Internet Res. 2024. 26:e57970.
    DOI: 10.2196/57970.
  3. Stress-Induced Sensitization of Insula Activation Predicts Alcohol Craving and Alcohol Use in Alcohol Use Disorder.
    Bach P, Zaiser J, Zimmermann S, Gessner T, Hoffmann S, Gerhardt S, Berhe O, Bekier NK, Abel M, Radler P, Langejurgen J, Tost H, Lenz B, Vollstadt-Klein S, Stallkamp J, Kirschbaum C, and Kiefer F. Biol Psychiatry. 2024. 95(3):245-255.
    DOI: 10.1016/j.biopsych.2023.08.024.
  4. Beyond Huntington's Disease - Late-Onset Chorea Caused by a Homozygous Variant in ERCC4.
    Barthel PC, Popa B, Ebert A, Mohamed SA, Weishaupt J, and Conrad J. Cerebellum. 2024. 24(1):5.
    DOI: 10.1007/s12311-024-01755-1. 
  5. [Acute ischemic stroke and troponin elevation: update of the Mannheim clinical algorithm].
    Becker L, Alonso A, Kruska M, Baumann S, Grassl N, Lesch H, Eisele P, Sieburg T, Behnes M, Schupp T, Kayed H, Platten M, Duerschmied D, Szabo K, Akin I, and Fastner C. Inn Med (Heidelb). 2024. 65(8):830-839.
    DOI: 10.1007/s00108-024-01719-x.
  6. Implications of TRPM3 and TRPM8 for sensory neuron sensitisation.
    Behrendt M. Biol Chem. 2024. 405(9-10):583-599.
    DOI: 10.1515/hsz-2024-0045.
  7. Non-motor symptoms in patients with amyotrophic lateral sclerosis: current state and future directions.
    Bjelica B, Bartels MB, Hesebeck-Brinckmann J, and Petri S. J Neurol. 2024. 271(7):3953-3977.
    DOI: 10.1007/s00415-024-12455-5.
  8. Opportunities and challenges of single-cell and spatially resolved genomics methods for neuroscience discovery.
    Bonev B, Goncalo CB, Chen F, Codeluppi S, Corces MR, Fan J, Heiman M, Harris K, Inoue F, Kellis M, Levine A, Lotfollahi M, Luo C, Maynard KR, Nitzan M, Ramani V, Satijia R, Schirmer L, Shen Y, Sun N, Green GS, Theis F, Wang X, Welch JD, Gokce O, Konopka G, Liddelow S, Macosko E, Bayraktar O, Habib N, and Nowakowski TJ. Nat Neurosci. 2024. 27(12):2292-2309.
    DOI: 10.1038/s41593-024-01806-0.
  9. H3K27M neoepitope vaccination in diffuse midline glioma induces B and T cell responses across diverse HLA loci of a recovered patient.
    Boschert T, Kromer K, Lerner T, Lindner K, Haltenhof G, Tan CL, Jahne K, Poschke I, Bunse L, Eisele P, Grassl N, Mildenberger I, Sahm K, Platten M, Lindner JM, and Green EW. Sci Adv. 2024. 10(5):eadi9091.
    DOI: 10.1126/sciadv.adi9091.
  10. The Role of Perceived Stress in the Relation between Childhood Maltreatment and Severity of Alcohol Use Disorder: A Mediation Analysis.
    Bougelet E, Deffaa M, Turkmen C, Kiefer F, Vollstadt-Klein S, and Gerhardt S. Eur Addict Res. 2024:1-10.
    DOI: 10.1159/000539711.
  11. A TBK1 variant causes autophagolysosomal and motoneuron pathology without neuroinflammation in mice.
    Brenner D, Sieverding K, Srinidhi J, Zellner S, Secker C, Yilmaz R, Dyckow J, Amr S, Ponomarenko A, Tunaboylu E, Douahem Y, Schlag JS, Rodriguez Martinez L, Kislinger G, Niemann C, Nalbach K, Ruf WP, Uhl J, Hollenbeck J, Schirmer L, Catanese A, Lobsiger CS, Danzer KM, Yilmazer-Hanke D, Munch C, Koch P, Freischmidt A, Fetting M, Behrends C, Parlato R, and Weishaupt JH. J Exp Med. 2024. 221(5).
    DOI: 10.1084/jem.20221190.
  12. Mass-Guided Single-Cell MALDI Imaging of Low-Mass Metabolites Reveals Cellular Activation Markers.
    Cairns JL, Huber J, Lewen A, Jung J, Maurer SJ, Bausbacher T, Schmidt S, Levkin PA, Sevin D, Gopfrich K, Koch P, Kann O, and Hopf C. Adv Sci (Weinh). 2024:e2410506.
    DOI: 10.1002/advs.202410506.
  13. More on the Influence of Gender Equality on Gender Differences in Economic Preferences.
    Cerioli S and Formozov A. Jahrbucher Fur Nationalokonomie Und Statistik. 2024. 244(1-2):131-148.
    DOI: 10.1515/jbnst-2022-0072.
  14. T-FINDER: A highly sensitive, pan-HLA platform for functional T cell receptor and ligand discovery.
    Cetin M, Pinamonti V, Schmid T, Boschert T, Mellado Fuentes A, Kromer K, Lerner T, Zhang J, Herzig Y, Ehlert C, Hernandez-Hernandez M, Samaras G, Torres CM, Fisch L, Dragan V, Kouwenhoven A, Van Schoubroeck B, Wils H, Van Hove C, Platten M, Green EW, Stevenaert F, Felix NJ, and Lindner JM. Sci Adv. 2024. 10(5):eadk3060.
    DOI: 10.1126/sciadv.adk3060.
  15. Systematic review and co-ordinate based meta-analysis to summarize the utilization of functional brain imaging in conjunction with human models of peripheral and central sensitization.
    Clarke S, Rogers R, Wanigasekera V, Fardo F, Pia H, Nochi Z, Macian N, Leray V, Finnerup NB, Pickering G, Mouraux A, Truini A, Treede RD, Garcia-Larrea L, and Tracey I. Eur J Pain. 2024.
    DOI: 10.1002/ejp.2251.
  16. Upregulated miR-10b-5p as a potential miRNA signature in amyotrophic lateral sclerosis patients.
    Dash BP, Freischmidt A, Helferich AM, Ludolph AC, Andersen PM, Weishaupt JH, and Hermann A. Front Cell Neurosci. 2024. 18:1457704.
    DOI: 10.3389/fncel.2024.1457704.
  17. An integrative miRNA-mRNA expression analysis identifies miRNA signatures associated with SOD1 and TARDBP patient-derived motor neurons.
    Dash BP, Freischmidt A, Weishaupt JH, and Hermann A. Hum Mol Genet. 2024.
    DOI: 10.1093/hmg/ddae072.
  18. Cranioencephalic functional lymphoid units in glioblastoma.
    Dobersalske C, Rauschenbach L, Hua Y, Berliner C, Steinbach A, Gruneboom A, Kokkaliaris KD, Heiland DH, Berger P, Langer S, Tan CL, Stenzel M, Landolsi S, Weber F, Darkwah Oppong M, Werner RA, Gull H, Schroder T, Linsenmann T, Buck AK, Gunzer M, Stuschke M, Keyvani K, Forsting M, Glas M, Kipnis J, Steindler DA, Reinhardt HC, Green EW, Platten M, Tasdogan A, Herrmann K, Rambow F, Cima I, Sure U, and Scheffler B. Nat Med. 2024.
    DOI: 10.1038/s41591-024-03152-x.
  19. Measuring interpersonal trauma: Development and validation of the German version of the victimization experience schedule (VES).
    Drusko A, Renz M, Schmidt H, Rosin M, Simon J, Beiner E, Charalambides M, Meyer-Lindenberg A, Treede RD, Tost H, and Tesarz J. J Psychosom Res. 2024. 179:111626.
    DOI: 10.1016/j.jpsychores.2024.111626.
  20. M2ara: unraveling metabolomic drug responses in whole-cell MALDI mass spectrometry bioassays.
    Enzlein T, Geisel A, Hopf C, and Schmidt S. Bioinformatics. 2024.
    DOI: 10.1093/bioinformatics/btae694.
  21. Integrative Single-Plaque Analysis Reveals Signature Abeta and Lipid Profiles in the Alzheimer's Brain.
    Enzlein T, Lashley T, Sammour DA, Hopf C, and Chavez-Gutierrez L. Anal Chem. 2024.
    DOI: 10.1021/acs.analchem.3c05557.
  22. Cue-exposure treatment influences resting-state functional connectivity-a randomized controlled fMRI study in alcohol use disorder.
    Farre-Colomes A, Tan H, Gerhardt S, Gerchen MF, Kirsch M, Hoffmann S, Kirsch P, Kiefer F, and Vollstadt-Klein S. Psychopharmacology (Berl). 2024.
    DOI: 10.1007/s00213-024-06531-x.
  23. Cell-cell contacts prevent t-BuOOH-triggered ferroptosis and cellular damage in vitro by regulation of intracellular calcium.
    Faust D, Wenz C, Holm S, Harms G, Greffrath W, and Dietrich C. Arch Toxicol. 2024.
    DOI: 10.1007/s00204-024-03792-5.
  24. Functioning in chronic pain: a call for a global definition.
    Freynhagen R, Fullen BM, Reneman MF, and Treede RD. Pain. 2024.
    DOI: 10.1097/j.pain.0000000000003307.
  25. Placebo and nocebo responses in painful diabetic neuropathy: systematic review and meta-analysis.
    Frisaldi E, Vollert J, Al Sultani H, Benedetti F, and Shaibani A. Pain. 2024. 165(1):29-43.
    DOI: 10.1097/j.pain.0000000000003000.
  26. Tumoral Interferon Beta Induces an Immune-Stimulatory Phenotype in Tumor-Associated Macrophages in Melanoma Brain Metastases.
    Gellert J, Agardy DA, Kumar S, Kourtesakis A, Boschert T, Jahne K, Breckwoldt MO, Bunse L, Wick W, Davies MA, Platten M, and Bunse T. Cancer Res Commun. 2024. 4(8):2189-2202.
    DOI: 10.1158/2767-9764.CRC-24-0024.
  27. L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy in newly-diagnosed glioblastoma: dose escalation of the phase I/II GLORIA trial.
    Giordano FA, Layer JP, Leonardelli S, Friker LL, Turiello R, Corvino D, Zeyen T, Schaub C, Muller W, Sperk E, Schmeel LC, Sahm K, Oster C, Kebir S, Hambsch P, Pietsch T, Bisdas S, Platten M, Glas M, Seidel C, Herrlinger U, and Holzel M. Nat Commun. 2024. 15(1):4210.
    DOI: 10.1038/s41467-024-48416-9.
  28. Bottom-up synthetic immunology.
    Gopfrich K, Platten M, Frischknecht F, and Fackler OT. Nat Nanotechnol. 2024.
    DOI: 10.1038/s41565-024-01744-9.
  29. Benefits of early MR-Imaging in patients with acute spontaneous intracerebral hemorrhage: a retrospective study.
    Grund B, Ebert A, Sandikci V, Neumaier-Probst E, and Alonso A. BMC Neurol. 2024. 24(1):487.
    DOI: 10.1186/s12883-024-03992-7.
  30. From Smoking to Vaping: The Motivation for E-Cigarette Use at the Neurobiological Level - An fMRI Study.
    Grundinger N, Andreas M, Lohner V, Schneider S, Mons U, and Vollstadt-Klein S. Nicotine Tob Res. 2024.
    DOI: 10.1093/ntr/ntae273.
  31. Patient engagement in designing, conducting, and disseminating clinical pain research: IMMPACT recommended considerations.
    Haroutounian S, Holzer KJ, Kerns RD, Veasley C, Dworkin RH, Turk DC, Carman KL, Chambers CT, Cowan P, Edwards RR, Eisenach JC, Farrar JT, Ferguson M, Forsythe LP, Freeman R, Gewandter JS, Gilron I, Goertz C, Grol-Prokopczyk H, Iyengar S, Jordan I, Kamp C, Kleykamp BA, Knowles RL, Langford DJ, Mackey S, Malamut R, Markman J, Martin KR, McNicol E, Patel KV, Rice ASC, Rowbotham M, Sandbrink F, Simon LS, Steiner DJ, and Vollert J. Pain. 2024. 165(5):1013-1028.
    DOI: 10.1097/j.pain.0000000000003121.
  32. GABAergic interneuron diversity and organization are crucial for the generation of human-specific functional neural networks in cerebral organoids.
    Heesen SH and Kohr G. Front Cell Neurosci. 2024. 18:1389335.
    DOI: 10.3389/fncel.2024.1389335.
  33. PerSurge (NOA-30) phase II trial of perampanel treatment around surgery in patients with progressive glioblastoma.
    Heuer S, Burghaus I, Gose M, Kessler T, Sahm F, Vollmuth P, Venkataramani V, Hoffmann D, Schlesner M, Ratliff M, Hopf C, Herrlinger U, Ricklefs F, Bendszus M, Krieg SM, Wick A, Wick W, and Winkler F. BMC Cancer. 2024. 24(1):135.
    DOI: 10.1186/s12885-024-11846-1.
  34. Associations of Menstrual Cycle and Progesterone-to-Estradiol Ratio With Alcohol Consumption in Alcohol Use Disorder: A Sex-Separated Multicenter Longitudinal Study.
    Hoffmann S, Gerhardt S, Muhle C, Reinhard I, Reichert D, Bach P, Boroumand-Jazi R, Kuehner C, Aguilera A, Aslan A, Bahr NS, Belanger M, Deeken F, Ebrahimi C, Fischbach PC, Ganz M, Garbusow M, Grosskopf CM, Heigert M, Hentschel A, Karl D, Liu S, Mazza M, Pelz P, Pinger M, Reichl M, Riemerschmid C, Rosenthal A, Steffen J, Strehle J, Wedemeyer F, Weiss F, Wenzel J, Wieder G, Wieland A, Zaiser J, Zech HG, Zimmermann S, Kornhuber J, Muller CP, Sommer WH, Spanagel R, Banaschewski T, Deserno L, Ebner-Priemer UW, Flor H, Kirsch P, Rietschel M, Vollstadt-Klein S, Walter H, Meyer-Lindenberg A, Rapp MA, Witt S, Smolka MN, Heinz A, Tost H, Kiefer F, Reichert M, Lenz B, and ReCoDe C. Am J Psychiatry. 2024:appiajp20230027.
    DOI: 10.1176/appi.ajp.20230027.
  35. Placebo analgesia in physical and psychological interventions: Systematic review and meta-analysis of three-armed trials.
    Hohenschurz-Schmidt D, Phalip J, Chan J, Gauhe G, Soliman N, Vollert J, Lunde SJ, and Vase L. Eur J Pain. 2024. 28(4):513-531.
    DOI: 10.1002/ejp.2205.
  36. Skin microdialysis detects distinct immunologic patterns in chronic inflammatory skin diseases.
    Hollstein MM, Traidl S, Heetfeld A, Forkel S, Leha A, Alkon N, Ruwisch J, Lenz C, Schon MP, Schmelz M, Brunner P, Steinhoff M, and Buhl T. J Allergy Clin Immunol. 2024.
    DOI: 10.1016/j.jaci.2024.06.024.
  37. Schwann cells in neuromuscular in vitro models.
    Horner SJ, Couturier N, Hafner M, and Rudolf R. Biol Chem. 2024. 405(1):25-30.
    DOI: 10.1515/hsz-2023-0172.
  38. A brave new framework for glioma drug development.
    Hotchkiss KM, Karschnia P, Schreck KC, Geurts M, Cloughesy TF, Huse J, Duke ES, Lathia J, Ashley DM, Nduom EK, Long G, Singh K, Chalmers A, Ahluwalia MS, Heimberger A, Bagley S, Todo T, Verhaak R, Kelly PD, Hervey-Jumper S, de Groot J, Patel A, Fecci P, Parney I, Wykes V, Watts C, Burns TC, Sanai N, Preusser M, Tonn JC, Drummond KJ, Platten M, Das S, Tanner K, Vogelbaum MA, Weller M, Whittle JR, Berger MS, and Khasraw M. Lancet Oncol. 2024. 25(10):e512-e519.
    DOI: 10.1016/S1470-2045(24)00190-6.
  39. Cerebrospinal Fluid cfDNA Sequencing for Classification of Central Nervous System Glioma.
    Iser F, Hinz F, Hoffmann DC, Grassl N, Gungoor C, Meyer J, Dorner L, Hofmann L, Kelbch V, Gobel K, Mahmutoglu MA, Vollmuth P, Patel A, Nguyen D, Kaulen LD, Mildenberger I, Sahm K, Maass K, Pajtler KW, Shankar GM, Weiler M, Wildemann B, Winkler F, von Deimling A, Platten M, Wick W, Sahm F, and Kessler T. Clin Cancer Res. 2024. 30(14):2974-2985.
    DOI: 10.1158/1078-0432.CCR-23-2907.
  40. Identification of galectin-3 as a novel potential prognostic/predictive biomarker and therapeutic target for cerebral cavernous malformation disease.
    Kar S, Perrelli A, Bali KK, Mastrocola R, Kar A, Khan B, Gand L, Nayak A, Hartmann C, Kunz WS, Samii A, Bertalanffy H, and Retta SF. Genes Dis. 2024. 11(1):67-71.
    DOI: 10.1016/j.gendis.2023.02.045.
  41. Differentiating Glioma Recurrence and Pseudoprogression by APTw CEST MRI.
    Karimian-Jazi K, Enbergs N, Golubtsov E, Schregel K, Ungermann J, Fels-Palesandro H, Schwarz D, Sturm V, Kernbach JM, Batra D, Ippen FM, Pfluger I, von Knebel Doeberitz N, Heiland S, Bunse L, Platten M, Winkler F, Wick W, Paech D, Bendszus M, and Breckwoldt MO. Invest Radiol. 2024.
    DOI: 10.1097/RLI.0000000000001145.
  42. The immunoglobulin superfamily ligand B7H6 subjects T cell responses to NK cell surveillance.
    Kilian M, Friedrich MJ, Lu KH, Vonhoren D, Jansky S, Michel J, Keib A, Stange S, Hackert N, Kehl N, Hahn M, Habel A, Jung S, Jahne K, Sahm F, Betge J, Cerwenka A, Westermann F, Dreger P, Raab MS, Meindl-Beinker NM, Ebert M, Bunse L, Muller-Tidow C, Schmitt M, and Platten M. Sci Immunol. 2024. 9(95):eadj7970.
    DOI: 10.1126/sciimmunol.adj7970.
  43. Safety, tolerability, and efficacy of fasudil in amyotrophic lateral sclerosis (ROCK-ALS): a phase 2, randomised, double-blind, placebo-controlled trial.
    Koch JC, Leha A, Bidner H, Cordts I, Dorst J, Gunther R, Zeller D, Braun N, Metelmann M, Corcia P, De La Cruz E, Weydt P, Meyer T, Grosskreutz J, Soriani MH, Attarian S, Weishaupt JH, Weyen U, Kuttler J, Zurek G, Rogers ML, Feneberg E, Deschauer M, Neuwirth C, Wuu J, Ludolph AC, Schmidt J, Remane Y, Camu W, Friede T, Benatar M, Weber M, Lingor P, and group R-AS. Lancet Neurol. 2024. 23(11):1133-1146.
    DOI: 10.1016/S1474-4422(24)00373-9.
  44. Oxaliplatin-induced Acute Neurotoxicity Recovers Between Repeat Infusion Cycles: An Axonal Excitability Repeated Multiple Measurements Study.
    Kokotis P, Papantoniou M, Carr RW, Schmelz M, Siakavella D, Skafida E, and Papadimitriou C. Cancer Diagn Progn. 2024. 4(3):320-325.
    DOI: 10.21873/cdp.10327.
  45. Patients' perspective on the chronic pain classification in the 11th revision of the International Classification of Diseases (ICD-11): results from an international web-based survey.
    Korwisi B, Hay G, Forget P, Ryan D, Treede RD, Rief W, and Barke A. Pain. 2024.
    DOI: 10.1097/j.pain.0000000000003248.
  46. NLGN4X TCR transgenic T cells to treat gliomas.
    Kramer C, Kilian M, Chih YC, Kourtesakis A, Hoffmann DC, Boschert T, Koopmann P, Sanghvi K, De Roia A, Jung S, Jahne K, Day B, Shultz LD, Ratliff M, Harbottle R, Green EW, Will R, Wick W, Platten M, and Bunse L. Neuro Oncol. 2024. 26(2):266-278.
    DOI: 10.1093/neuonc/noad172.
  47. The peroxisome: an update on mysteries 3.0.
    Kumar R, Islinger M, Worthy H, Carmichael R, and Schrader M. Histochem Cell Biol. 2024.
    DOI: 10.1007/s00418-023-02259-5.
  48. Neural deception: Breast cancer co-opts neuronal mechanisms to evade the immune system.
    Layer N, Bunse L, and Venkataramani V. Cancer Cell. 2024.
    DOI: 10.1016/j.ccell.2024.05.007.
  49. Cell type mapping reveals tissue niches and interactions in subcortical multiple sclerosis lesions.
    Lerma-Martin C, Badia IMP, Ramirez Flores RO, Sekol P, Schafer PSL, Riedl CJ, Hofmann A, Thawel T, Wunnemann F, Ibarra-Arellano MA, Trobisch T, Eisele P, Schapiro D, Haeussler M, Hametner S, Saez-Rodriguez J, and Schirmer L. Nat Neurosci. 2024.
    DOI: 10.1038/s41593-024-01796-z.
  50. Clinical Features and Voxel-Based-Symptom-Lesion Mapping of Silent Aspiration in Acute Infratentorial Stroke.
    Lesch H, Wittayer M, Dias M, Nick A, Ebert A, Eisele P, and Alonso A. Dysphagia. 2024. 39(2):289-298.
    DOI: 10.1007/s00455-023-10611-z.
  51. Iron scavenging and myeloid cell polarization.
    Ludwig N, Cucinelli S, Hametner S, Muckenthaler MU, and Schirmer L. Trends Immunol. 2024.
    DOI: 10.1016/j.it.2024.06.006.
  52. Prognostic factors for overall survival in elderly patients with glioblastoma: Analysis of the pooled NOA-08 and Nordic trials with the CCTG-EORTC (CE.6) trial.
    Malmstrom A, Oppong FB, CJ OC, Wick W, Laperriere N, Gorlia T, Weller M, Henriksson R, Mason W, Platten M, Cantagallo E, Gronberg BH, Reifenberger G, Marosi C, Perry JR, Ncbtsg NC, and Group EBT. Neurooncol Adv. 2024. 6(1):vdae211.
    DOI: 10.1093/noajnl/vdae211.
  53. Interferential Current Stimulation of Rectal Motor Activity - Objective Data from the Isolated Perfused Porcine Rectum.
    Martel R, Boettcher M, Klinke M, Hoyos NA, Herrmann I, Magerl W, and Herrmann M. Eur J Pediatr Surg. 2024.
    DOI: 10.1055/a-2482-5997.
  54. Intra-arterial delivery of neurospheres into isolated perfused porcine colons: a proof of concept.
    Martel RD, Hoyos NA, Tapia-Laliena MA, Herrmann I, Herrmann M, Khasanov R, and Schafer KH. Biol Methods Protoc. 2024. 9(1):bpae022.
    DOI: 10.1093/biomethods/bpae022.
  55. Interindividual variability in cold-pressor pain sensitivity is not explained by peripheral vascular responding and generalizes to a C-nociceptor-specific pain phenotype.
    Martel RD, Papafragou G, Weigand S, Rolke R, Prawitt D, Birklein F, Treede RD, and Magerl W. Pain. 2024.
    DOI: 10.1097/j.pain.0000000000003049.
  56. MediMer: a versatile do-it-yourself peptide-receptive MHC class I multimer platform for tumor neoantigen-specific T cell detection.
    Meyer M, Parpoulas C, Barthelemy T, Becker JP, Charoentong P, Lyu Y, Borsig S, Bulbuc N, Tessmer C, Weinacht L, Ibberson D, Schmidt P, Pipkorn R, Eichmuller SB, Steinberger P, Lindner K, Poschke I, Platten M, Frohling S, Riemer AB, Hassel JC, Roberti MP, Jager D, Zornig I, and Momburg F. Front Immunol. 2023. 14:1294565.
    DOI: 10.3389/fimmu.2023.1294565.
  57. Serum neurofilament light chain in distinct phenotypes of amyotrophic lateral sclerosis: A longitudinal, multicenter study.
    Meyer T, Dreger M, Grehl T, Weyen U, Kettemann D, Weydt P, Gunther R, Lingor P, Petri S, Koch JC, Grosskreutz J, Rodiger A, Baum P, Hermann A, Prudlo J, Boentert M, Weishaupt JH, Loscher WN, Dorst J, Koc Y, Bernsen S, Cordts I, Vidovic M, Steinbach R, Metelmann M, Kleinveld VE, Norden J, Ludolph A, Walter B, Schumann P, Munch C, Kortvelyessy P, and Maier A. Eur J Neurol. 2024. 31(9):e16379.
    DOI: 10.1111/ene.16379.
  58. SOD1 gene screening in ALS - frequency of mutations, patients' attitudes to genetic information and transition to tofersen treatment in a multi-center program.
    Meyer T, Schumann P, Grehl T, Weyen U, Petri S, Rodiger A, Steinbach R, Grosskreutz J, Bernsen S, Weydt P, Wolf J, Gunther R, Vidovic M, Baum P, Metelmann M, Weishaupt JH, Streubel B, Kasper DC, Koc Y, Kettemann D, Norden J, Schmitt P, Walter B, Munch C, Spittel S, Maier A, and Kortvelyessy P. Amyotroph Lateral Scler Frontotemporal Degener. 2024:1-10.
    DOI: 10.1080/21678421.2024.2401131.
  59. Clinical and patient-reported outcomes and neurofilament response during tofersen treatment in SOD1-related ALS-A multicenter observational study over 18 months.
    Meyer T, Schumann P, Weydt P, Petri S, Weishaupt JH, Weyen U, Koch JC, Gunther R, Regensburger M, Boentert M, Wiesenfarth M, Koc Y, Kolzarek F, Kettemann D, Norden J, Bernsen S, Elmas Z, Conrad J, Valkadinov I, Vidovic M, Dorst J, Ludolph AC, Hesebeck-Brinckmann J, Spittel S, Munch C, Maier A, and Kortvelyessy P. Muscle Nerve. 2024. 70(3):333-345.
    DOI: 10.1002/mus.28182.
  60. New ICD-11 diagnostic criteria for chronic secondary musculoskeletal pain associated with Parkinson disease.
    Mylius V, Moisset X, Rukavina K, Rosner J, Korwisi B, Marques A, Lloret SP, Kagi G, Bohlhalter S, Bannister K, Chaudhuri KR, Barke A, Tinazzi M, Brefel-Courbon C, Treede RD, and de Andrade DC. Pain. 2024.
    DOI: 10.1097/j.pain.0000000000003138.
  61. Type 1 Myocardial Infarction in Patients With Acute Ischemic Stroke.
    Nolte CH, von Rennenberg R, Litmeier S, Leistner DM, Szabo K, Baumann S, Mengel A, Michalski D, Siepmann T, Blankenberg S, Petzold GC, Dichgans M, Katus H, Pieske B, Regitz-Zagrosek V, Braemswig TB, Rangus I, Pepic A, Vettorazzi E, Zeiher AM, Scheitz JF, Wegscheider K, Landmesser U, and Endres M. JAMA Neurol. 2024.
    DOI: 10.1001/jamaneurol.2024.1552.
  62. Salivary Testosterone Levels and Pain Perception Exhibit Sex-Specific Association in Healthy Adults But Not in Patients With Migraine.
    Pan LH, Chen SP, Ling YH, Wang YF, Lai KL, Liu HY, Chen WT, Huang WJ, Coppola G, Treede RD, and Wang SJ. J Pain. 2024:104575.
    DOI: 10.1016/j.jpain.2024.104575.
  63. Celebrating the 30th Anniversary of the European Association of Neuro-Oncology (EANO).
    Preusser M, Platten M, and Short SC. Neuro Oncol. 2024.
    DOI: 10.1093/neuonc/noae039.
  64. A generalizable deep voxel-guided morphometry algorithm for the detection of subtle lesion dynamics in multiple sclerosis.
    Raj A, Gass A, Eisele P, Dabringhaus A, Kraemer M, and Zollner FG. Front Neurosci. 2024. 18:1326108.
    DOI: 10.3389/fnins.2024.1326108.
  65. Deep-learning-based reconstruction of undersampled MRI to reduce scan times: a multicentre, retrospective, cohort study.
    Rastogi A, Brugnara G, Foltyn-Dumitru M, Mahmutoglu MA, Preetha CJ, Kobler E, Pfluger I, Schell M, Deike-Hofmann K, Kessler T, van den Bent MJ, Idbaih A, Platten M, Brandes AA, Nabors B, Stupp R, Bernhardt D, Debus J, Abdollahi A, Gorlia T, Tonn JC, Weller M, Maier-Hein KH, Radbruch A, Wick W, Bendszus M, Meredig H, Kurz FT, and Vollmuth P. Lancet Oncol. 2024. 25(3):400-410.
    DOI: 10.1016/S1470-2045(23)00641-1.
  66. Myosin Va: Capturing cAMP for synaptic plasticity.
    Rudolf R. Front Physiol. 2023. 14:1342994.
    DOI: 10.3389/fphys.2023.1342994.
  67. Sympathetic innervation in skeletal muscle and its role at the neuromuscular junction.
    Rudolf R, Kettelhut IC, and Navegantes LCC. J Muscle Res Cell Motil. 2024.
    DOI: 10.1007/s10974-024-09665-9.
  68. Generalized anxiety is a predictor of impaired quality of life in patients with atrial fibrillation: Findings from the prospective observational ARENA study.
    Sadlonova M, Salzmann S, Senges J, Celano CM, Huffman JC, Borggrefe M, Akin I, Thomas D, Schwarzbach CJ, Kleemann T, Schneider S, Hochadel M, Suselbeck T, Schwacke H, Alonso A, Haass M, Ladwig KH, and Herrmann-Lingen C. J Psychosom Res. 2024. 176:111542.
    DOI: 10.1016/j.jpsychores.2023.111542.
  69. [Immunotherapy against gliomas].
    Sahm K and Weiss T. Nervenarzt. 2024.
    DOI: 10.1007/s00115-023-01590-5.
  70. optiPRM: A targeted immunopeptidomics LC-MS workflow with ultra-high sensitivity for the detection of mutation-derived tumor neoepitopes from limited input material.
    Salek M, Forster JD, Becker JP, Meyer M, Charoentong P, Lyu Y, Lindner K, Lotsch C, Volkmar M, Momburg F, Poschke I, Frohling S, Schmitz M, Offringa R, Platten M, Jager D, Zornig I, and Riemer AB. Mol Cell Proteomics. 2024:100825.
    DOI: 10.1016/j.mcpro.2024.100825.
  71. Label-free assessment of complement-dependent cytotoxicity of therapeutic antibodies via a whole-cell MALDI mass spectrometry bioassay.
    Schmidt S, Geisel A, Enzlein T, Frohlich BC, Pritchett L, Verneret M, Graf C, and Hopf C. Sci Rep. 2024. 14(1):21462.
    DOI: 10.1038/s41598-024-71483-3.
  72. In-depth analysis of data from the RAS-ALS study reveals new insights in rasagiline treatment for amyotrophic lateral sclerosis.
    Schuster J, Dreyhaupt J, Monkemoller K, Dupuis L, Dieterle S, Weishaupt JH, Kassubek J, Petri S, Meyer T, Grosskreutz J, Schrank B, Boentert M, Emmer A, Hermann A, Zeller D, Prudlo J, Winkler AS, Grehl T, Heneka MT, Johannesen S, Goricke B, Witzel S, Dorst J, Ludolph AC, and Group R-AS. Eur J Neurol. 2024:e16204.
    DOI: 10.1111/ene.16204.
  73. Electrical matrix stimulation suppresses acute itch independently of activation of sleeping nociceptors.
    Schwarzenauer M, Rukwied RM, Lampert A, Rolke R, and Namer B. Eur J Pain. 2024. 28(2):285-296.
    DOI: 10.1002/ejp.2177.
  74. Analysis of the Mouse Hepatic Peroxisome Proteome-Identification of Novel Protein Constituents Using a Semi-Quantitative SWATH-MS Approach.
    Singin O, Astapenka A, Costina V, Kuhl S, Bonekamp N, Drews O, and Islinger M. Cells. 2024. 13(2).
    DOI: 10.3390/cells13020176.
  75. Depolarization of mouse DRG neurons by GABA does not translate into acute pain or hyperalgesia in healthy human volunteers.
    Sohns K, Kostenko A, Behrendt M, Schmelz M, Rukwied R, and Carr R. PLoS One. 2024. 19(8):e0307668.
    DOI: 10.1371/journal.pone.0307668.
  76. Improving neuropathic pain treatment - by rigorous stratification from bench to bedside.
    Soliman N, Kersebaum D, Lawn T, Sachau J, Sendel M, and Vollert J. J Neurochem. 2024. 168(11):3699-3714.
    DOI: 10.1111/jnc.15798.
  77. Sustained nerve growth factor-induced C-nociceptor sensitization to electrical sinusoidal stimulation in humans.
    Solinski HJ, Schmelz M, and Rukwied R. Pain Rep. 2024. 9(5):e1190.
    DOI: 10.1097/PR9.0000000000001190.
  78. The ReCoDe addiction research consortium: Losing and regaining control over drug intake-Findings and future perspectives.
    Spanagel R, Bach P, Banaschewski T, Beck A, Bermpohl F, Bernardi RE, Beste C, Deserno L, Durstewitz D, Ebner-Priemer U, Endrass T, Ersche KD, Feld G, Gerchen MF, Gerlach B, Goschke T, Hansson AC, Heim C, Kiebel S, Kiefer F, Kirsch P, Kirschbaum C, Koppe G, Lenz B, Liu S, Marxen M, Meinhardt MW, Meyer-Lindenberg A, Montag C, Muller CP, Nagel WE, Oliveria AMM, Owald D, Pilhatsch M, Priller J, Rapp MA, Reichert M, Ripke S, Ritter K, Romanczuk-Seiferth N, Schlagenhauf F, Schwarz E, Schwobel S, Smolka MN, Soekadar SR, Sommer WH, Stock AK, Strohle A, Tost H, Vollstadt-Klein S, Walter H, Waschke T, Witt SH, Heinz A, and other members of the ReCoDe C. Addict Biol. 2024. 29(7):e13419.
    DOI: 10.1111/adb.13419.
  79. Skin Innervation.
    Stander S and Schmelz M. J Invest Dermatol. 2024. 144(8):1716-1723.
    DOI: 10.1016/j.jid.2023.10.047.
  80. Tumor biomechanics as a novel imaging biomarker to assess response to immunotherapy in a murine glioma model.
    Streibel Y, Breckwoldt MO, Hunger J, Pan C, Fischer M, Turco V, Boztepe B, Fels-Palesandro H, Scheck JG, Sturm V, Karimian-Jazi K, Agardy DA, Annio G, Mustapha R, Soni SS, Alasa A, Weidenfeld I, Rodell CB, Wick W, Heiland S, Winkler F, Platten M, Bendszus M, Sinkus R, and Schregel K. Sci Rep. 2024. 14(1):15613.
    DOI: 10.1038/s41598-024-66519-7.
  81. Impulse initiation in engrafted pluripotent stem cell-derived cardiomyocytes can stimulate the recipient heart.
    Studemann T, Schwarzova B, Schneidewind T, Geertz B, von Bibra C, Nehring M, Rossinger J, Wiegert JS, Eschenhagen T, and Weinberger F. Stem Cell Reports. 2024.
    DOI: 10.1016/j.stemcr.2024.06.012.
  82. Treatment of glioblastoma patients with personalized vaccines outside clinical trials: Lessons ignored
    Tabatabai G, Platten M, Preusser M, Weller M, Wick W, and van den Bent M. Neuro Oncol. 2024.
    DOI: 10.1093/neuonc/noae225.
  83. Associations of preterm birth and neonatal stress exposure with chronic pain in adulthood - Results from the Gutenberg prematurity study.
    Tesarz J, Schuster AK, Hermes M, Mildenberger E, Urschitz MS, Treede RD, Tost H, Ernst M, Beutel M, Stoffelns B, Zepp F, Pfeiffer N, and Fiess A. J Psychosom Res. 2024. 187:111943.
    DOI: 10.1016/j.jpsychores.2024.111943.
  84. High-Throughput Miniaturized Synthesis of PROTAC-Like Molecules.
    Tian Y, Seifermann M, Bauer L, Luchena C, Wiedmann JJ, Schmidt S, Geisel A, Afonin S, Hopfner J, Brehm M, Liu X, Hopf C, Popova AA, and Levkin PA. Small. 2024:e2307215.
    DOI: 10.1002/smll.202307215.
  85. Interactions between 2 subtypes of central sensitization in rats and humans: spinal long-term potentiation and brainstem controls.
    Treede RD. Pain. 2024.
    DOI: 10.1097/j.pain.0000000000003167.
  86. Slow depolarizing electrical stimuli reveal differential time courses of nociceptor recovery after prolonged topical capsaicin in human skin.
    Tumbala Gutti D, Carr R, Schmelz M, and Rukwied R. Eur J Pain. 2024.
    DOI: 10.1002/ejp.4726.
  87. Sports participation moderates the risk of family-specific negative life events on alcohol use among adolescents: Evidence from the longitudinal MyLife study.
    Turkmen C, Brunborg GS, Lund IO, Kiefer F, Vollstadt-Klein S, and Burdzovic Andreas J. Addict Behav. 2024. 155:108041.
    DOI: 10.1016/j.addbeh.2024.108041.
  88. Paradoxical heat sensation as a manifestation of thermal hypesthesia: a study of 1090 patients with lesions of the somatosensory system.
    Vollert J, Fardo F, Attal N, Baron R, Bouhassira D, Enax-Krumova EK, Freynhagen R, Hansson P, Jensen TS, Kersebaum D, Maier C, Pogatzki-Zahn E, Rice ASC, Sachau J, Schaldemose EL, Segerdahl M, Sendel M, Tolle TR, Finnerup NB, and Treede RD. Pain. 2024. 165(1):216-224.
    DOI: 10.1097/j.pain.0000000000003014.
  89. TRPV1 Channel in Human Eosinophils: Functional Expression and Inflammatory Modulation.
    Weihrauch T, Gray N, Wiebe D, Schmelz M, Limberg MM, and Raap U. Int J Mol Sci. 2024. 25(3).
    DOI: 10.3390/ijms25031922.
  90. Tofersen decreases neurofilament levels supporting the pathogenesis of the SOD1 p.D91A variant in amyotrophic lateral sclerosis patients.
    Weishaupt JH, Kortvelyessy P, Schumann P, Valkadinov I, Weyen U, Hesebeck-Brinckmann J, Weishaupt K, Endres M, Andersen PM, Regensburger M, Dreger M, Koch JC, Conrad J, and Meyer T. Commun Med (Lond). 2024. 4(1):150.
    DOI: 10.1038/s43856-024-00573-0.
  91. Chairing scientific sessions at international neuro-oncology meetings: An EANO guide for early-career professionals.
    Werner JM, Petrescu GED, Boele F, Preusser M, Platten M, Chalmers AJ, Short SC, and Piil K. Neurooncol Pract. 2024. 11(6):673-676.
    DOI: 10.1093/nop/npae060.
  92. Effects of tofersen treatment in patients with SOD1-ALS in a "real-world" setting - a 12-month multicenter cohort study from the German early access program.
    Wiesenfarth M, Dorst J, Brenner D, Elmas Z, Parlak O, Uzelac Z, Kandler K, Mayer K, Weiland U, Herrmann C, Schuster J, Freischmidt A, Muller K, Siebert R, Bachhuber F, Simak T, Gunther K, Frohlich E, Knehr A, Regensburger M, German A, Petri S, Grosskreutz J, Klopstock T, Reilich P, Schoberl F, Hagenacker T, Weyen U, Gunther R, Vidovic M, Jentsch M, Haarmeier T, Weydt P, Valkadinov I, Hesebeck-Brinckmann J, Conrad J, Weishaupt JH, Schumann P, Kortvelyessy P, Meyer T, Ruf WP, Witzel S, Senel M, Tumani H, and Ludolph AC. EClinicalMedicine. 2024. 69:102495.
    DOI: 10.1016/j.eclinm.2024.102495.
  93. A bistable inhibitory optoGPCR for multiplexed optogenetic control of neural circuits.
    Wietek J, Nozownik A, Pulin M, Saraf-Sinik I, Matosevich N, Gowrishankar R, Gat A, Malan D, Brown BJ, Dine J, Imambocus BN, Levy R, Sauter K, Litvin A, Regev N, Subramaniam S, Abrera K, Summarli D, Goren EM, Mizrachi G, Bitton E, Benjamin A, Copits BA, Sasse P, Rost BR, Schmitz D, Bruchas MR, Soba P, Oren-Suissa M, Nir Y, Wiegert JS, and Yizhar O. Nat Methods. 2024.
    DOI: 10.1038/s41592-024-02285-8.
  94. Cell type mapping of inflammatory muscle diseases highlights selective myofiber vulnerability in inclusion body myositis.
    Wischnewski S, Thawel T, Ikenaga C, Kocharyan A, Lerma-Martin C, Zulji A, Rausch HW, Brenner D, Thomas L, Kutza M, Wick B, Trobisch T, Preusse C, Haeussler M, Leipe J, Ludolph A, Rosenbohm A, Hoke A, Platten M, Weishaupt JH, Sommer CJ, Stenzel W, Lloyd TE, and Schirmer L. Nat Aging. 2024.
    DOI: 10.1038/s43587-024-00645-9.
  95. From evidence to care delivery: Opportunities and risks in health and science policy. A position paper of the Association of the Scientific Medical Societies in Germany (AWMF).
    Wormann B, Kopp I, Nothacker M, Klar E, Sedlmayr M, Vogeser M, Schliephake H, and Treede RD. Ger Med Sci. 2024. 22:Doc10.
    DOI: 10.3205/000336.
  96. Alzheimer's disease linked Abeta42 exerts product feedback inhibition on gamma-secretase impairing downstream cell signaling.
    Zoltowska KM, Das U, Lismont S, Enzlein T, Maesako M, Houser MCQ, Franco ML, Ozcan B, Gomes Moreira D, Karachentsev D, Becker A, Hopf C, Vilar M, Berezovska O, Mobley W, and Chavez-Gutierrez L. Elife. 2024. 12.
    DOI: 10.7554/eLife.90690.